I agree, there are many OTC companies overvalued for no reason at all, it seems the two I have are both undervalued. They will rise in time. I can see this going to low 20's and fluctuating there until Q2 revs or Fluticare approval, which I think would double, if not, almost double the share price. All they need is the doctors that prescribe the Rx version to say oh you can get it over the counter now, and that will get a lot of sales. I can also see another company wanting Fluticare for themselves, more money to shelf it and advertise nationally. I believe the company is going in the right direction. Getting rid of debt, keeping margins high. Unlike other posters on this board I believe in Damaj. He may have had some hiccups but I trust him. A big thing for me is that he won a congressional medal for an anthrax test. He doesn't seem like he's trying to scam anyone. He put his own money into the company as well. A lot of shares around this price or more for options for the workers too, I can't see it staying at these levels.
